Abstract:Norfloxacin (NORF) is a broad-spectrum quinolone that is widely utilized for the treatment of various bacterial infections and is considered one of the most commonly used fluoroquinolone antibiotics. However, NORF's clinical utility is limited by its poor water solubility and relatively low oral bioavailability. This study presents an optimization and synergistic enhancement approach through salt/co-crystal, aiming to maximize the biopharmaceutical properties of NORF with the use of phenolic acid. Following this strategy, two new hydrate salts of NORF with phenolic acid, namely, NORF—3,5-DBA hydrate (salt 1) and NORF—VA hydrate (salt 2), were prepared and systematically confirmed. Two hydrate salts were produced by means of the slow evaporation crystallization method, and the structures were determined through single-crystal X-ray diffraction (SCXRD). Additionally, powder X-ray diffraction (PXRD), Fourier-transform infrared (FT-IR) spectroscopy, differential scanning calorimetry (DSC), thermogravimetric analysis (TGA), and high-performance liquid chromatography (HPLC) were applied to analyze the features of the two salts. The experimental results indicated that the formation of the two salts could enhance the solubility and improve the release behavior of NORF. Interestingly, the physicochemical properties of NORF were significantly improved as a result, leading to an enhancement in its antibacterial activity. This was demonstrated by the enhanced inhibition of bacterial strains and the lower minimum inhibitory concentration values.

Crystal Structure of Norfloxacin Picrate,(c16h19fn3o3)[c6h2(no2)3o]

X-Ray Crystal Structures of Mg2+ and Ca2+ Dimers of the Antibacterial Drug Norfloxacin

Norfloxacinium nitrate

2d Nanoporous Molecular Square Grid: Manganese (Ii) Norfloxacin Complex

Crystallographic Report: Bis(norfloxacin)dilead(II) Tetranitrate, [Pb2(h‐norf)2(ono2)4]

Crystal Structure of Ethyl 1-(4-fluorobenzyl)-3-phenyl-1h-pyrazole-5-carboxylate, C19H17FN2O2

Two Polymeric Complexes of Norfloxacin with Iron(II) and Their Magnetic Properties

2D Molecular Square Grid with Strong Blue Fluorescent Emission: A Complex of Norfloxacin with Zinc(II)

Synthesis and Characterization of a New Norfloxacin/Resorcinol Cocrystal with Enhanced Solubility and Dissolution Profile

Synthesis, crystal structure, and characterization of mixed-ligand complex of copper(I) with drug of norfloxacin and triphenyl phosphine: [Cu(PPh3)2(H-Norf)]ClO4

Crystal Structure of N-(1-Benzyl-2-Oxoindolin-3-Yl)-N-P-Tolylbenzofuran-2-Carboxamide, C31h24n2o3

Two Novel Hydrate Salts of Norfloxacin with Phenolic Acids and Their Physicochemical Properties

A Neutral 2D Nanosized Molecular Square Grid: the First Vanadium(ii)coordination Polymer of Norfloxacin

Crystal Structure, Spectral, Thermo-Gravimetric and Antibacterial Properties of Zn(Ⅱ) Ofloxacin Complex

The Crystal Structure Of A Gatifloxacin Complex And Its Fluorescent Property

Molecular dynamics simulation of the norfloxacin-DNA complex

Synthesis, Crystal Structure And Antitumor Activity Of Mixed Ligand Coordination Compound Of Copper With Norfloxacin And 1,10-Phen, [Cu(Nflx)(Phen)(H2o)] No3 Center Dot 3h(2)O

A mononuclear complex of norfloxacin with silver(I) and its properties

Crystal Structure of (E)-2-fluoro-6-((4-hydroxyphenethylimino)methyl)phenol, C15h14fno2

The Crystal Structure of (E)-3-chloro-2-(2-(2-fluorobenzylidene)hydrazinyl)pyridine, C12H9ClFN3

Study on the Structure, Solubilities, Antibacterial Activities and In Vivo Toxicity of Hesperetin and Norfloxacin Cocrystal